Pneumonia caused by Chlamydia pneumoniae bacteria
Part of Infections, Lungs & breathing clinical trials.
This study looks at patients who had pneumonia caused by a specific bacteria called Chlamydia pneumoniae. It aims to learn more about this type of pneumonia to help improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Had a positive test for Chlamydia pneumoniae in a nose or lung sample between 2015 and 2025.
- Had medical records that confirm you had pneumonia.
- You do not object to your medical data being used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults with community-acquired pneumonia, using symptom checks and chest X-ray results. It may help researchers better understand what pneumonia looks like in the community and how it progresses.
This trial looks at which “pneumococcus” (a common germ) types are causing pneumonia in people admitted to the hospital. It uses a urine test kit to see how often different pneumococcal types are involved, which may help future treatment choices.
This trial studies treatment for pneumonia by enrolling people who have pneumonia signs on a chest X-ray plus typical symptoms like fever, cough, trouble breathing, or chest pain. It may help doctors test approaches for better outcomes after pneumonia.
This study looks at the germs in your lungs to understand why some people's pneumonia doesn't get better with standard antibiotics. If you are hospitalized with pneumonia and have just started treatment, you may be asked to provide a sputum sample so researchers can study your lung microbiome.
This study looks at adults with pneumonia caught outside the hospital. It aims to understand what symptoms they have and how well they recover, which could help doctors treat this condition better.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.